40 related articles for article (PubMed ID: 18928637)
1. ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele.
Skowronska A; Austen B; Powell JE; Weston V; Oscier DG; Dyer MJ; Matutes E; Pratt G; Fegan C; Moss P; Taylor MA; Stankovic T
Haematologica; 2012 Jan; 97(1):142-6. PubMed ID: 21933854
[TBL] [Abstract][Full Text] [Related]
2. Rare Germline
Lampson BL; Gupta A; Tyekucheva S; Mashima K; Petráčková A; Wang Z; Wojciechowska N; Shaughnessy CJ; Baker PO; Fernandes SM; Shupe S; Machado JH; Fardoun R; Kim AS; Brown JR
J Clin Oncol; 2023 Feb; 41(5):1116-1128. PubMed ID: 36315919
[TBL] [Abstract][Full Text] [Related]
3. Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: impact of genetic features.
Woyach JA; Lozanski G; Ruppert AS; Lozanski A; Blum KA; Jones JA; Flynn JM; Johnson AJ; Grever MR; Heerema NA; Byrd JC
Leukemia; 2012 Jun; 26(6):1442-4. PubMed ID: 22289993
[No Abstract] [Full Text] [Related]
4. The atm-1 gene is required for genome stability in Caenorhabditis elegans.
Jones MR; Huang JC; Chua SY; Baillie DL; Rose AM
Mol Genet Genomics; 2012 Apr; 287(4):325-35. PubMed ID: 22350747
[TBL] [Abstract][Full Text] [Related]
5. Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes.
; ; Zhou K; Bellenguez C; Spencer CC; Bennett AJ; Coleman RL; Tavendale R; Hawley SA; Donnelly LA; Schofield C; Groves CJ; Burch L; Carr F; Strange A; Freeman C; Blackwell JM; Bramon E; Brown MA; Casas JP; Corvin A; Craddock N; Deloukas P; Dronov S; Duncanson A; Edkins S; Gray E; Hunt S; Jankowski J; Langford C; Markus HS; Mathew CG; Plomin R; Rautanen A; Sawcer SJ; Samani NJ; Trembath R; Viswanathan AC; Wood NW; ; Harries LW; Hattersley AT; Doney AS; Colhoun H; Morris AD; Sutherland C; Hardie DG; Peltonen L; McCarthy MI; Holman RR; Palmer CN; Donnelly P; Pearson ER
Nat Genet; 2011 Feb; 43(2):117-20. PubMed ID: 21186350
[TBL] [Abstract][Full Text] [Related]
6. The role of ATM in response to metformin treatment and activation of AMPK.
Yee SW; Chen L; Giacomini KM
Nat Genet; 2012 Mar; 44(4):359-60. PubMed ID: 22456732
[No Abstract] [Full Text] [Related]
7. Familial chronic lymphocytic leukemia in two siblings with ATM/13q14 deletion and a similar pattern of clonal evolution.
Kostopoulos IV; Tsakiridou AA; Pavlidis D; Megalakaki A; Papadhimitriou SI
Blood Cancer J; 2015 Jul; 5(7):e322. PubMed ID: 26140430
[No Abstract] [Full Text] [Related]
8. Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
Boultwood J
J Clin Pathol; 2001 Jul; 54(7):512-6. PubMed ID: 11429421
[TBL] [Abstract][Full Text] [Related]
9. Chronic lymphocytic leukemia and treatment resistance in cancer: the role of the p53 pathway.
Zenz T; Benner A; Döhner H; Stilgenbauer S
Cell Cycle; 2008 Dec; 7(24):3810-4. PubMed ID: 19098429
[TBL] [Abstract][Full Text] [Related]
10. [Gene atm and chronic lymphocytic leukemia - review].
Zhu DX; Xu W; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1242-6. PubMed ID: 18928637
[TBL] [Abstract][Full Text] [Related]
11. Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage.
Britt-Compton B; Lin TT; Ahmed G; Weston V; Jones RE; Fegan C; Oscier DG; Stankovic T; Pepper C; Baird DM
Leukemia; 2012 Apr; 26(4):826-30. PubMed ID: 21986843
[No Abstract] [Full Text] [Related]
12. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia.
Starostik P; Manshouri T; O'Brien S; Freireich E; Kantarjian H; Haidar M; Lerner S; Keating M; Albitar M
Cancer Res; 1998 Oct; 58(20):4552-7. PubMed ID: 9788599
[TBL] [Abstract][Full Text] [Related]
13. A putative "hepitype" in the ATM gene associated with chronic lymphocytic leukemia risk.
Martín-Guerrero I; Enjuanes A; Richter J; Ammerpohl O; Colomer D; Ardanaz M; Marco F; Salas A; Campo E; Siebert R; García-Orad A
Genes Chromosomes Cancer; 2011 Nov; 50(11):887-95. PubMed ID: 21910157
[TBL] [Abstract][Full Text] [Related]
14. Increased transferrin receptor expression following 11q23 deletion as a mechanism of malignant progression in chronic lymphocytic leukemia.
Shackelford RE; Bhalodia AR; Cotelingam JD; Veillon DM; Lowery-Nordberg M
Med Hypotheses; 2006; 66(3):509-12. PubMed ID: 16326028
[TBL] [Abstract][Full Text] [Related]
15. ATM mutations in B-cell chronic lymphocytic leukemia.
Bullrich F; Rasio D; Kitada S; Starostik P; Kipps T; Keating M; Albitar M; Reed JC; Croce CM
Cancer Res; 1999 Jan; 59(1):24-7. PubMed ID: 9892178
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
